Lu Chris Xiangyang increased his holdings of LAEKNA-B (02105) by 17,200 shares, with each share priced at approximately HK$7.07.
On July 9th, Lu Chris Xiangyang increased his holdings of Lai Kai Medicine-B (02105) by 17,200 shares, with a price of 7.0726 Hong Kong dollars per share, totaling approximately 121,600 Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on July 9th, Lu Chris Xiangyang increased his holdings of LAEKNA-B (02105) by 17,200 shares, at a price of 7.0726 Hong Kong dollars per share, totaling approximately 121,600 Hong Kong dollars. After the increase, the latest number of shares held is approximately 55,137,600 shares, with a latest shareholding percentage of 12.27%.
Related Articles
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
RECOMMEND
